Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Martin Watterson

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Shock (Augusta, Ga.)|June 20, 2007
A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperpermeability during severe burnsRashell Reynoso, Rachel M Perrin, Jerome W Breslin, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 28, 2025
Optimized 5-HT<sub>2b</sub> inhibitors for neuropsychiatric syndromes with cognitive dysfunctionSaktimayee M Roy, Erica Acquarone, Elentina K Argyrousi, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
An aminopyridazine-based inhibitor of a pro-apoptotic protein kinase attenuates hypoxia-ischemia induced acute brain injuryAnastasia V Velentza, Mark S Wainwright, Magdalena Zasadzki, et al.
Journal of Medicinal Chemistry|April 13, 2019
A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive DysfunctionSaktimayee M Roy, George Minasov, Ottavio Arancio, et al.
Journal of Muscle Research and Cell Motility|March 13, 2003
Smooth muscle myosin filament assembly under control of a kinase-related protein (KRP) and caldesmonDmitry S Kudryashov, Alexander V Vorotnikov, Tatyana V Dudnakova, et al.
The American Journal of Pathology|January 27, 2007
Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null miceHantamalala Ralay Ranaivo, Nunzia Carusio, Rosemary Wangensteen, et al.
Bioorganic & Medicinal Chemistry|March 10, 2009
Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailabilityGraham R Lawton, Hantamalala Ralay Ranaivo, Laura K Chico, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2018
p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouseMatthew J Robson, Meagan A Quinlan, Kara Gross Margolis, et al.
Alzheimer'S Research & Therapy|December 16, 2016
Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathologyNicole Maphis, Shanya Jiang, Guixiang Xu, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosisTian Chen, Radhia Benmohamed, Anthony C Arvanites, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Shock (Augusta, Ga.)|June 20, 2007
A role for long chain myosin light chain kinase (MLCK-210) in microvascular hyperpermeability during severe burnsRashell Reynoso, Rachel M Perrin, Jerome W Breslin, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 28, 2025
Optimized 5-HT<sub>2b</sub> inhibitors for neuropsychiatric syndromes with cognitive dysfunctionSaktimayee M Roy, Erica Acquarone, Elentina K Argyrousi, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 2003
An aminopyridazine-based inhibitor of a pro-apoptotic protein kinase attenuates hypoxia-ischemia induced acute brain injuryAnastasia V Velentza, Mark S Wainwright, Magdalena Zasadzki, et al.
Journal of Medicinal Chemistry|April 13, 2019
A Selective and Brain Penetrant p38αMAPK Inhibitor Candidate for Neurologic and Neuropsychiatric Disorders That Attenuates Neuroinflammation and Cognitive DysfunctionSaktimayee M Roy, George Minasov, Ottavio Arancio, et al.
Journal of Muscle Research and Cell Motility|March 13, 2003
Smooth muscle myosin filament assembly under control of a kinase-related protein (KRP) and caldesmonDmitry S Kudryashov, Alexander V Vorotnikov, Tatyana V Dudnakova, et al.
The American Journal of Pathology|January 27, 2007
Protection against endotoxic shock as a consequence of reduced nitrosative stress in MLCK210-null miceHantamalala Ralay Ranaivo, Nunzia Carusio, Rosemary Wangensteen, et al.
Bioorganic & Medicinal Chemistry|March 10, 2009
Analogues of 2-aminopyridine-based selective inhibitors of neuronal nitric oxide synthase with increased bioavailabilityGraham R Lawton, Hantamalala Ralay Ranaivo, Laura K Chico, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2018
p38α MAPK signaling drives pharmacologically reversible brain and gastrointestinal phenotypes in the SERT Ala56 mouseMatthew J Robson, Meagan A Quinlan, Kara Gross Margolis, et al.
Alzheimer'S Research & Therapy|December 16, 2016
Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathologyNicole Maphis, Shanya Jiang, Guixiang Xu, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Arylsulfanyl pyrazolones block mutant SOD1-G93A aggregation. Potential application for the treatment of amyotrophic lateral sclerosisTian Chen, Radhia Benmohamed, Anthony C Arvanites, et al.
Pageof 8